Immunomodulative effect of glucan and/or glucan supplemented with zinc in albendazole therapy for murine alveolar echinococcosis

Parasitology Research

Volumn 101, Issue 3, 2007, Pages 751-760

  Porubcová, Jarmila ^a   Dvorožňáková, Emília ^a   Ševčíková, Zuzana ^b  

^a PARASITOLOGICAL INSTITUTE   (Slovakia)

^b UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; GAMMA INTERFERON; GLUCAN; GLUCAN PLUS ZINC; INTERLEUKIN 5; SUPEROXIDE; UNCLASSIFIED DRUG; ZINC DERIVATIVE;

ALVEOLAR ECHINOCOCCOSIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; DRUG EFFECT; DRUG INHIBITION; ECHINOCOCCOSIS; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN CELL; STIMULATION; SUPPLEMENTATION; T LYMPHOCYTE;

MURINAE; MUS;

EID: 34547118548     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-007-0545-4     Document Type: Article

References (49)

1. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 31:787-793
2. Ammann RW, Hirsbrunner R, Cotting J, Steiger U, Jacquier P, Eckert J (1990) Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results). Am J Trop Med Hyg 43:506-515
3. Anttinen H, Ryhanen L, Puistola U, Arranto A, Oikarinen A (1984) Decrease in liver collagen accumulation in carbon tetrachloride-injured and normal growing rats upon administration of zinc. Gastroenterology 86:532-539
4. Bach JF (1983) The multi-faceted zinc dependency of the immune system. Immunol Today 4:225-227
5. Baum MK, Shor-Posner G, Campa A (2000) Zinc status in human immunodeficiency virus infection. J Nutr 130:S1421-S1423
6. Borošková Z, Dvorožňáková E, Dubinský P, Velebný S, Tomašovičová O, Machnická B (1998) Effect of free and liposomised albendazole on the immune responses in healthy and Toxocara canis infected mice. Vet Med Czech 43:293-300
7. Borošková Z, Dvorožňáková E, Ševčíková Z (2003) Cellular immune reactions of mice with alveolar echinococcosis after albendazole therapy. Helminthologia 40:187-194
8. Bresson-Hadni S, Liance M, Meyer JP, Houin R, Bresson JL, Vuitton DA (1990) Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin Exp Immunol 82:378-383
9. Casini A, Ceni E, Salzano R, Biondi P, Parola M, Galli A, Foschi M, Caligiuri A, Pinzani M, Surrenti C (1997) Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology 25:361-367
10. Chowdhury N, Singh R (1989) Distribution of zinc in parasitic helminths. J Helminthol 63:149-152
11. Crea A, Guérin V, Ortega F, Hartemann P (1990) Zinc et systeme immunitaire. Ann Med Interne 141:447-451
12. Ditteová G, Velebný S, Hrčková G (2003) Modulation of liver fibrosis and pathophysiological changes in mice infected with Mesocestoides corti (M. vogae) after administration of glucan and liposomized glucan in combination with vitamin C. J Helminthol 77:219-226
13. Dixon JB (1997) Echinococcosis. Comp Immunol Microbiol Infect Dis 20:87-94
14. Dowd PS, Kelleher J, Guillou PJ (1986) T-lymphocyte subsets and interleukin-2 production in zinc-deficient rats. Br J Nutr 55:59-69
15. Dvorožňáková E, Akao A (2000) Th1 and Th2 response after glucan immunomodulation in murine larval toxocarosis. Reports Czech Parasitol Soc S8:53
16. Dvorožňáková E, Hrčková G, Borošková Z, Velebný S, Dubinský P (2004) Effect of treatment with free and liposomized albendazole on selected immunological parameters and cyst growth in mice infected with Echinococcus multilocularis. Parasitol Int 53:315-325
17. Gottstein B, Hemphill A (1997) Immunopathology of echinococcosis. Chem Immunol 66:177-208
18. Gottstein B, Haag K, Walker M, Matsumoto J, Mejri A, Hemphill A (2006) Molecular survival strategies of Echinococcus multilocularis in the murine host. Parasitol Int 55:S45-S49
19. Guerret S, Vuitton DA, Liance M, Pater C, Carbillet JP (1998) Echinococcus multilocularis: relationship between susceptibility/resistance and liver fibrogenesis in experimental mice. Parasitol Res 84:657-667
20. Hrčková G, Velebný S (1997) Effect of praziquantel and liposome-incorporated praziquantel on peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia (Cestoda). Parasitology 114:475-482
21. Hrčková G, Velebný S, Daxnerová Z, Solar P (2006) Praziquantel and liposomized glucan-treatment modulated liver fibrogenesis and mastocytosis in mice infected with Mesocestoides vogae (M. corti, Cestoda) tetrathyridia. Parasitology 132:581-594
22. James K (1990) Interactions between cytokines and alpha 2-macroglobulin. Immunol Today 11:163-166
23. Kidd PM (2000) The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 5:4-27
24. Kinčeková J, Hrčková G, Auer H, Szilágyiová M, Hudačková J, Stanislayová M, Poláček H, Šimeková K (2006) Clinical and serological study of human alveolar echinococcosis in Slovakia in relation to the outcome of chemotherapy. Helminthologia 43:213-219
25. Kizaki T, Ishige M, Kobayashi S, Bingyan W, Kumagai M, Day NK, Good RA, Onoe K (1993) Suppression of T-cell proliferation by CD8+ T cells induced in the presence of protoscolices of Echinococcus multilocularis in vitro. Infect Immunity 61:525-533
26. Kojima-Yuasa A, Umeda K, Ohkita T, Opare Kennedy D, Nishiguchi S, Matsui-Yuasa I (2005) Role of reactive oxygen species in zinc deficiency-induced hepatic stellate cell activation. Free Radic Biol Med 39:631-640
27. Liance M, Ricard-Blum S, Emery I, Houin R, Vuitton DA (1998) Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite 5:231-237
28. Manfras BJ, Reuter S, Wendland T, Boehm BO, Kern P (2004) Impeded Th1 CD4 memory T cell generation in chronic-persisting liver infection with Echinococcus multilocularis. Int Immunol 16:43-50
29. Miterpáková M, Antolová D, Ševč íková Z, Stanko M, Dinkel A, Gašpar V, Dubinský P (2006a) Echinococcus multilocularis in musk rat (Ondatra zibethicus): the first finding of the parasite in naturally infected rodent in the Slovak Republic. Helminthologia 43:76-80
30. Miterpáková M, Dubinský P, Reiterová K, Stanko M (2006b) Climate and environmental factors influencing Echinococcus multilocularis occurrence in the Slovak Republic. Ann Agric Environ Med 13:235-242
31. Pagé M, Bajaouni N, Ciqo-Mars B, Lemieux P (1988) Optimization the tetrazolium based colorimetric assay for the measurement of cell number and cytotoxicity. Int J Immunopharmacol 10:785-793
32. Pérez-Serrano J, Denegri G, Casado N, Rodriguez-Caabeiro F (1997) In vivo effect of oral albendazole and albendazole sulphoxide on development of secondary echinococcosis in mice. Int J Parasitol 27:1341-1345
33. Reuter S, Jensen B, Buttenschoen K, Kratzer W, Kern P (2000) Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature. J Antimicrob Chemother 46:451-456
34. Rink L, Kirchner H (2000) Zinc-altered immune function and cytokine production. J Nutr 130:S1407-S1411
35. Sakurai T, Kaise T, Yadomae T, Matsubara C (1997) Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1→3)-beta-d-glucan. Eur J Pharmacol 334:255-263
36. Šoltýs J, Quinn MT (1999) Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan. Infect Immun 67:244-252
37. Šoltýs J, Benková M, Borošková Z (1994) Immunorestorative effect of glucan immunomodulator on guinea pigs with experimental ascariosis. Vet Immunol Immunopathol 42:379-388
38. Šoltýs J, Borošková Z, Dubinský P, Tomašovičová O, Auer H, Aspock H (1996) Effect of glucan immunomodulator on the immune response and larval burdens in mice with experimental toxocarosis. Appl Parasitol 37:161-167
39. Song YL, Ford JW, Gordon D, Shanley CJ (2000) Regulation of lysyl oxidase by interferon-gamma in rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 20:982-988
40. Sturm D, Menzel J, Gottstein B, Kern P (1995) Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 63:1688-1697
41. Tang JT, Fang JY, Gu WQ, Li EL (2006) T cell immune response is correlated with fibrosis and inflammatory activity in hepatitis B cirrhotics. World J Gastroenterol 12:3015-3019
42. Venkatesan P (1998) Albendazole. J Antimicrob Chemother 41:145-147
43. Větvička V, Thornton BP, Ross GD (1996) Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest 98:50-61
44. Vuitton DA (1999) New trends in the treatment of echinococcosis. Helminthologia 36:167-170
45. Vuitton DA (2003) The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop 85:119-132
46. Vuitton DA, Zhang SL, Yang Y, Godot V, Beurton I, Mantion G, Bresson-Hadni S (2006) Survival strategy of Echinococcus multilocularis in the human host. Parasitol Int 55:S51-S55
47. Wellinghausen N, Kirchner H, Rink L (1997) The immunobiology of zinc. Immunol Today 18:519-521
48. Wellinghausen N, Jochle W, Reuter S, Flegel Wa, Grunert A, Kern P (1999) Zinc status in patients with alveolar echinococcosis is related to disease progression. Parasite Immunol 21:237-241
49. Wilson JF, Rausch RL, Wilson FR (1995) Alveolar hydatid disease. Review of the surgical experience in 42 cases of active disease among Alaskan Eskimos. Ann Surg 221:315-323